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Dear Editor,
Several  lines  of  evidence  imply  that  hepatitis  D  virus 
(HDV)  infection  has  a  worldwide  distribution.  It  is  quite 
common in some areas such as Russia, Romania, Southern 
Italy, Mediterranean countries, Africa, South American (Ven-
ezuela,  Columbia,  Brazil,  and  Ecuador)  and  China  (1).  We 
conducted  this  study  to  determine  the  seroprevalence  of 
HDV in Shahrekord, a small city in Charmahal-o-Bakhtiyari 
province, West of Iran and compared it with the results of 
studies carried out in the larger cities in Iran. We studied 
11,472 (9602 men and 1870 women) volunteer blood donors. 
All  participants  completed  a  questionnaire  including  so-
ciodemographic data, past medical history of symptomatic 
hepatitis, gender, age, educational level and their residence 
(urban vs. rural). Blood samples taken from donors were 
checked for HBsAg and IgM against HBcAg (Table 1). In HB-
sAg-positive cases, anti-HDV antibody level was determined 
at the baseline using frozen serum specimens by enzyme-
linked immunosorbent assay (ELISA). The results were com-
pared between HDV-positive and -negative cases. This study 
was approved by the Research Ethics Committee of Shah-
rekord Azad University and conducted with help of Blood 
Transfusion Organization. Data were analyzed with SPSS ver 
9.0 (SPSS Inc., Chicago, IL) using x² test. Continuous variables 
are presented as Mean±SD.The studied participants had a 
mean age of 27 (range: 18–64) years. There were 8849 (83.7%) 
men and 8151 of them (77.1%) were married. The rate of tattoo-
ing, blood letting and suspicious sexual contacts were 34%, 
17% and 3%, respectively. HBsAg was found positive in 0.78% of 
participants (90 of 11,472—67 men and 13 women); 13 (0.11%) 
and 6 (0.05%) of whom were seropositive for HBc-Ab and 
HDV-Ab, respectively. Among seropositive samples for HB-
sAg, 6.6% were seropositive for anti-HDV IgG. No significant 
association was observed between HDV seropositivity and 
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Table 1. Serological data of the participant blood donors
a  Hepatitis B surface antigen (HBSAg)
b  Hepatitis B core antigen (IgM-HBc)
c  Hepatitis D virus (HDV)
d  13 and 6 were positive from 90 HBsAg-positive cases
Indicator Positive cases Percentage of 
total
Percentage of 
HBS-Ag + cases
HBsAg a 90 0.78 100%
IgM HBc b 13d 0.11 14.4%
Anti-HDV c 6d 0.05 6.6%131 Tajbakhsh E et al. Anti-HDV among HBsAg-positive blood donors
Hepat Mon. 2011;11(2):130-131
sociodemographic  characteristics.In  Iran,  seroprevalence 
of HDV infection varies from 2.4% in blood donors to 10% 
in chronic liver disease patients (2). In asymptomatic carri-
ers of HBsAg from Jordan, Kuwait, Saudi Arabia, and Turkey 
the seroprevalence rate was reported as 2%, 31%, 3.3%, 5.2%, 
respectively  (3).  Its  prevalence  in  acute  hepatitis  patients 
from Egypt, Jordan, Kuwait and Tajikestan was reported to 
be 16.94%, 16%, 4% and 9.2%, respectively. The rate in chronic 
liver disease patients from Yemen, Turkey, Jordan and Egypt 
was 2%, 32.7%, 23% and 23.53%, respectively (3). The seropreva-
lence rate of 6.6% for anti-HDV IgG among volunteer blood 
donors referred to Shahrekord Blood Bank is much less than 
that reported earlier. 
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